These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 7556412

  • 1. Cyclosporin A is a substance P (tachykinin NK1) receptor antagonist.
    Gitter BD, Waters DC, Threlkeld PG, Lovelace AM, Matsumoto K, Bruns RF.
    Eur J Pharmacol; 1995 May 26; 289(3):439-46. PubMed ID: 7556412
    [Abstract] [Full Text] [Related]

  • 2. Identification of both NK1 and NK2 receptors in guinea-pig airways.
    McKee KT, Millar L, Rodger IW, Metters KM.
    Br J Pharmacol; 1993 Oct 26; 110(2):693-700. PubMed ID: 7694756
    [Abstract] [Full Text] [Related]

  • 3. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
    Catalioto RM, Criscuoli M, Cucchi P, Giachetti A, Gianotti D, Giuliani S, Lecci A, Lippi A, Patacchini R, Quartara L, Renzetti AR, Tramontana M, Arcamone F, Maggi CA.
    Br J Pharmacol; 1998 Jan 26; 123(1):81-91. PubMed ID: 9484857
    [Abstract] [Full Text] [Related]

  • 4. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
    Maggi CA, Patacchini R, Meini S, Quartara L, Sisto A, Potier E, Giuliani S, Giachetti A.
    Br J Pharmacol; 1994 May 26; 112(1):150-60. PubMed ID: 7518302
    [Abstract] [Full Text] [Related]

  • 5. Characterisation of [125I][MePhe7]neurokinin B binding to tachykinin NK3 receptors: evidence for interspecies variance.
    Suman-Chauhan N, Grimson P, Guard S, Madden Z, Chung FZ, Watling K, Pinnock R, Woodruff G.
    Eur J Pharmacol; 1994 Sep 15; 269(1):65-72. PubMed ID: 7530207
    [Abstract] [Full Text] [Related]

  • 6. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
    Maggi CA, Patacchini R, Eglezos A, Quartara L, Giuliani S, Giachetti A.
    Br J Pharmacol; 1992 Sep 15; 107(1):27-33. PubMed ID: 1384907
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
    Rumsey WL, Aharony D, Bialecki RA, Abbott BM, Barthlow HG, Caccese R, Ghanekar S, Lengel D, McCarthy M, Wenrich B, Undem B, Ohnmacht C, Shenvi A, Albert JS, Brown F, Bernstein PR, Russell K.
    J Pharmacol Exp Ther; 2001 Jul 15; 298(1):307-15. PubMed ID: 11408556
    [Abstract] [Full Text] [Related]

  • 8. Autoradiographic localization of tachykinin NK2 and NK1 receptors in the guinea-pig lung, using selective radioligands.
    Strigas J, Burcher E.
    Eur J Pharmacol; 1996 Sep 12; 311(2-3):177-86. PubMed ID: 8891598
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
    Emonds-Alt X, Proietto V, Steinberg R, Oury-Donat F, Vigé X, Vilain P, Naline E, Daoui S, Advenier C, Le Fur G, Maffrand JP, Soubrié P, Pascal M.
    J Pharmacol Exp Ther; 2002 Dec 12; 303(3):1171-9. PubMed ID: 12438541
    [Abstract] [Full Text] [Related]

  • 11. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
    Patacchini R, Quartara L, Rolka K, Zboinska J, Kupryszewski G, Maggi CA.
    Eur J Pharmacol; 1993 Dec 07; 250(2):311-6. PubMed ID: 7509285
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
    Floch A, Fardin V, Cavero I.
    Br J Pharmacol; 1994 Mar 07; 111(3):759-68. PubMed ID: 7517328
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.
    Beattie DT, Beresford IJ, Connor HE, Marshall FH, Hawcock AB, Hagan RM, Bowers J, Birch PJ, Ward P.
    Br J Pharmacol; 1995 Dec 07; 116(8):3149-57. PubMed ID: 8719789
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonist.
    Robineau P, Lonchampt M, Kucharczyk N, Krause JE, Regoli D, Fauchere JL, Prost JF, Canet E.
    Eur J Pharmacol; 1995 Dec 29; 294(2-3):677-84. PubMed ID: 8750733
    [Abstract] [Full Text] [Related]

  • 20. Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801.
    Beaujouan JC, Saffroy M, Torrens Y, Glowinski J.
    Eur J Pharmacol; 1997 Jan 29; 319(2-3):307-16. PubMed ID: 9042606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.